rs587777893
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_004958.4(MTOR):c.5930C>T(p.Thr1977Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1977K) has been classified as Pathogenic.
Frequency
Consequence
NM_004958.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Published functional studies demonstrate constitutive activation of mTOR complex 1 and enlarged neuronal size (Mirzaa et al., 2016); Not observed in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 27159400, 30569621) -
This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 1977 of the MTOR protein (p.Thr1977Ile). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of MTOR-related conditions (PMID: 27159400, 30569621, 33833411). ClinVar contains an entry for this variant (Variation ID: 584432). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt MTOR protein function with a negative predictive value of 95%. Experimental studies have shown that this missense change affects MTOR function (PMID: 27159400). For these reasons, this variant has been classified as Pathogenic. -
Isolated focal cortical dysplasia type II Pathogenic:2
- -
The MTOR c.5930C>T (p.Thr1977Ile) variant was identified at an allelic fraction consistent with somatic origin. This variant has been reported in multiple individuals with brain malformations (Handoko, M et al. PMID: 30569621; Mirzaa GM et al., PMID: 27159400; Cao Y et al. PMID: 31349857) and has also been reported as a somatic variant in multiple cancer cases in the cancer database COSMIC (COSMIC ID: COSV63868784). The MTOR c.5930C>T (p.Thr1977Ile) variant has been reported in the ClinVar database as a pathogenic variant in both a somatic and germline state by numerous submitters (ClinVar ID: 584432). It is absent from the general population database (gnomAD v4.1.0), indicating it is not a common variant. The MTOR c.5930C>T (p.Thr1977Ile) variant resides within the FAT domain of MTOR that is defined as a critical functional domain (Xu J et al., PMID: 27482884; Mirzaa GM et al., PMID: 27159400). Other variants in the same codon, (p.Thr1977Lys and p.Thr1977Arg), have been reported in individuals with brain malformations and are considered pathogenic (Baldassari S et al., PMID: 31444548; Xu J et al., PMID: 27482884; ClinVar ID's: 1296989 and 156702). Computational predictors indicate that the variant is damaging, evidence that correlates with impact to MTOR function. In support of this prediction, in vitro functional studies showed that the p.Thr1977Ile variant activates mTOR complex 1 (mTORC1) signaling (Mirzaa GM et al., PMID: 27159400). The MTOR gene is defined by the ClinGen's Brain Malformations expert panel as a gene that has a low rate of benign missense variation and where pathogenic missense variants are a common mechanism of disease (Lai A et al., PMID: 35997716). Based on available information and an internally developed protocol informed by the ACMG/AMP guidelines for variant interpretation (Leon-Quintero FZ et al., PMID: 39434542) and the ClinGen Brain Malformation Variant Curation Expert Panel (Lai A et al, PMID: 35997716), the MTOR c.5930C>T (p.Thr1977Ile) variant is classified as pathogenic. -
MTOR-related megalencephaly and pigmentary mosaicism in skin Pathogenic:1
A mosaic c.5930C>T (p.T1977I) pathogenic variant in the MTOR gene was detected in this individual (level of mosaicism 32%, 55 mutant and 117 reference reads). This variant has been previously reported as mosaic in 3 unrelated children with diffuse megalencephaly and pigmentary mosaicism in skin [PMID 27159400]. This variant has also been seen as mosaic in one internal patient with macrocephaly, overgrowth, and other similar symptoms. This individual has been reported in PMID: 30569621. -
CEBALID syndrome Pathogenic:1
- -
MTOR-related disorder Pathogenic:1
PS3, PS4, PM2, PP3 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at